Trial intelligence / Profile preview

OZ439 in P. falciparum malaria

NCT01713621Phase 2Completed

Sponsor
Medicines for Malaria Venture
Start
Mar 2013
Primary completion
Apr 2015
Countries
1
01

Overview

A Phase 2 trial of artefenomel in Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Mar 2013; status: completed.

02

Drugs

artefenomel
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT01713621.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01713621.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call